Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Patients With Unexplained Recurrent Miscarriages
NCT01718340Phase 4Withdrawn
- Sponsor
- Woman's Health University Hospital
- Start
- Jun 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in recurrent miscarriage (RPL), sponsored by Woman's Health University Hospital. Planned start Jun 2012; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT01718340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718340.